GH/IGF‐1 axis dysregulation enhances the synergistic effect of GH and IGF‐1 on the promotion of uncontrolled cell proliferation, cell movement and angiogenesis, as well as the increase of neoplasia risk 11. The gene discussed is GH1; the disease is neoplasm.